An anti-parasitic drug could be the COVID-19 antiviral we need
Researchers from Australia have confirmed that an FDA-approved anti-parasitic agent called Ivermectin can inhibit SARS-Cov2 replication in…
The Encyclopedia of Science's Frontier
Researchers from Australia have confirmed that an FDA-approved anti-parasitic agent called Ivermectin can inhibit SARS-Cov2 replication in…
Scientists recently discovered key information about SARS-CoV-2 that could improve the medical treatment of patients with severe pneumonia.…
Questions surrounding the nature of asymptomatic cases of coronavirus disease 2019 (COVID-19) have been present since near the beginning of…
Do commercial hand sanitizers work on coronavirus? In the lab, yes. Studies are needed using real human hands, which come with ethical…
A potential way to speed up vaccine development: human challenge trials. #covid19 #research
Obesity and abnormal liver function have been predicted to play a part in extended hospitalization duration and worsen the health…
Are there better ways to detect the coronavirus in our body? A small study from China suggests antibody testing as a potentially more…
A group of scientists collected samples from some of the initially infected COVID-19 patients to show its similarities to other coronavirus…
Since December, 2019 a virus which causes the COVID-19 disease has been spreading, resulting in a global pandemic. While some questions…
Reality now matches what was predicted. According to models, travel restrictions alone would only delay the epidemic status of COVID-19. But…